The study, appearing in the society’s journal, GIE: Gastrointestinal Endoscopy, found that a patient detected with the new screening protocol was alive without evidence of recurrence three years after surgical resection.
The study said costs of the new screening protocol were acceptable: $8,431 to detect pancreatic neoplasia and $41,133 to detect pancreatic cancer.
Read the American Society for Gastrointestinal Endoscopy release on pancreatic cancer detection (pdf).
Related Articles on Pancreatic Cancer:
Expert Cautions Findings on Pancreatic Cancer Screening
New Research Supports Previous Studies Aspirin Reduces Risk of CRC
Study: Endoscopic Ultrasound Associated With Improved Pancreatic Cancer Outcomes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
